June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health ...

The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded ...

Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech ...

Cohere Health, a clinical intelligence company, launched a new solution called Review Assist, which speeds up medical necessity reviews for health plans, the company announced on Monday. Boston ...

Last November, the FDA approved MI Cancer Seek for use in six cancer indications as a companion diagnostic for certain targeted therapies, such as the Merck immunotherapy Keytruda and the Pfizer ...

Sword Health's $40 million funding round was led by General Catalyst. In total, the company has raised $300 million. The most recent round brings its valuation to $4 billion.

Despite their necessity, beds and surfaces do not always receive proportional attention and innovation — even as the risks associated with prolonged bed rest remain a key priority for caregivers.

Cigna launched these tools to make the customer experience as seamless as possible, according to Chris DeRosa, executive vice president of business improvement and innovation at The Cigna Group ...

AHIP, an advocacy organization for health insurers, is sounding the alarm over the potential impact of the 2025 budget reconciliation legislation, which includes significant cuts to Medicaid and ...

If the One Big Beautiful Bill Act is signed into law, it would result in a $50.4 billion reduction in federal Medicaid spending on rural hospitals over the next decade, which could put 338 rural ...

Bristol Myers Squibb is buying into this strategy, paying BioNTech $1.5 billion up front to collaborate on BNT327’s development. Each company may also test drugs from their own pipelines in ...

AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs ...